GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Healwell AI Inc (OTCPK:HWAIF) » Definitions » Float Percentage Of Total Shares Outstanding

HWAIF (Healwell AI) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 08, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Healwell AI Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Healwell AI's float shares is 0.00 Mil. Healwell AI's total shares outstanding is 292.35 Mil. Healwell AI's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Healwell AI's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Healwell AI's Institutional Ownership is 0.70%.


Healwell AI Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Healwell AI's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/292.35
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Healwell AI Business Description

Industry
Traded in Other Exchanges
Address
460 College Street, Unit 301, Toronto, ON, CAN, M6G 1A1
Healwell AI Inc is a healthcare technology company focused on AI and data science for preventative care. The group's proprietary AI technology and competencies, including data science, electronic health records, and clinical research offerings, enable it is develop and commercialize clinical decision support systems. Its tools help healthcare providers detect rare and chronic diseases, improve the efficiency of their practice, and ultimately help improve patient health outcomes.